Radiosensitizer
OwnerIchiro Hirotsu, Yuki Ohkawa +4inventors
InventorsIchiro Hirotsu, Yuki Ohkawa, Hisashi Yamamoto, Makoto Sato, Koichi Kobayashi, Hirohisa Horinouchi
Life of this patent
Estimating the term…
Abstract
There is provided a radiosensitizer containing an iron compound, more specifically, a radiosensitizer containing an iron compound selected from an inorganoiron compound, such as iron chloride, iron oxide, iron hydroxide, and iron sulfate; and an organoiron compound, such as saccharated ferric oxide, iron citrate, iron gluconate, chondroitin sulfate/iron colloid, cideferron, ferrotrenine, iron fumarate, iron pyrophosphate, a porphyrin-iron complex, and an albumin incorporating porphyrin-iron complex.
Claims21
A method for treating cancer using radiation therapy comprising administering to a patient suffering from cancer a chemotherapeutic agent and a radiosensitizer comprising an iron compound and thereafter administering radiation to the cancer.
The method of claim5, wherein iron in the porphyrin-iron complex is Fe(II).
A radiosensitizer comprising an iron compound in dosage form suitable for administration to a patient suffering from cancer.
Dependencies are inferred from the claim text.